JCA report reveals insights into market access implications for manufacturers, indicating future developments.
The first Joint Clinical Assessment (JCA) report has been completed. In this update we examine what this inaugural report reveals in practice and draw out the implications for manufacturers.
No takes yet. Share an insight, caveat, or question.
Ramagopalan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: